{"tm":1686892087,"s":"OCUL","news":[{"t":"Ocular Therapeutix Announces 12-Month Topline Data from Ongoing U.S.-Based Phase 1 Clinical Trial Evaluating OTX-TKI for Treatment of Wet AMD","dt":"Jun-10-23 06:30PM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-announces-12-month-223000035.html"},{"t":"Ocular Therapeutix, Inc. (NASDAQ:OCUL) is definitely on the radar of institutional investors who own 45% of the company","dt":"Jun-02-23 09:37AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-inc-nasdaq-ocul-133732405.html"},{"t":"Q1 2023 Ocular Therapeutix Inc Earnings Call","dt":"06:21AM","a":"Thomson Reuters StreetEvents","u":"https:\/\/finance.yahoo.com\/news\/q1-2023-ocular-therapeutix-inc-102112692.html"},{"t":"Ocular Therapeutix Provides First Quarter 2023 Financial Results and Corporate Update","dt":"04:01PM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-provides-first-quarter-200100627.html"},{"t":"Ocular Therapeutix To Present Data at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting","dt":"Apr-28-23 08:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-present-data-2023-120000120.html"},{"t":"Ocular Therapeutix (NASDAQ:OCUL) shareholders have endured a 21% loss from investing in the stock five years ago","dt":"Apr-07-23 08:49AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-nasdaq-ocul-shareholders-124958932.html"},{"t":"Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q4 2022 Earnings Call Transcript","dt":"07:21AM","a":"Insider Monkey","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-inc-nasdaq-ocul-122110054.html"},{"t":"Ocular Therapeutix (OCUL) Reports Q4 Loss, Tops Revenue Estimates","dt":"Mar-06-23 05:15PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-ocul-reports-q4-221510293.html"},{"t":"Chinook Therapeutics (KDNY) Reports Q4 Loss, Tops Revenue Estimates","dt":"Feb-27-23 05:15PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/chinook-therapeutics-kdny-reports-q4-221510918.html"},{"t":"Ocular Therapeutix Shares Jump On Favorable Data From Intravitreal Implant Study In Wet AMD","dt":"Feb-13-23 05:52AM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-shares-jump-favorable-105240653.html"},{"t":"With 48% stake, Ocular Therapeutix, Inc. (NASDAQ:OCUL) seems to have captured institutional investors' interest","dt":"Dec-24-22 07:34AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/48-stake-ocular-therapeutix-inc-123429894.html"},{"t":"Ocular Therapeutix (OCUL) Reports Q3 Loss, Lags Revenue Estimates (Revised)","dt":"05:38AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-ocul-reports-q3-103810786.html"},{"t":"Ocular Therapeutix Reports Third Quarter 2022 Financial Results and Business Update","dt":"04:01PM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-reports-third-quarter-210100591.html"},{"t":"Ocular Therapeutix (OCUL) Soars 24.2%: Is Further Upside Left in the Stock?","dt":"Sep-30-22 09:27AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-ocul-soars-24-132701643.html"},{"t":"Ocular Therapeutix To Present Data at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting","dt":"Sep-22-22 07:00AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-present-data-american-110000332.html"},{"t":"Ocular Therapeutix (OCUL) Reports Q2 Loss, Lags Revenue Estimates","dt":"Aug-08-22 05:45PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-ocul-reports-q2-214509366.html"},{"t":"Could The Ocular Therapeutix, Inc. (NASDAQ:OCUL) Ownership Structure Tell Us Something Useful?","dt":"Jul-13-22 01:58PM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/could-ocular-therapeutix-inc-nasdaq-175831088.html"},{"t":"Ocular Therapeutix to Present at the Jefferies Healthcare Conference","dt":"Jun-01-22 08:00AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-present-jefferies-healthcare-120000717.html"},{"t":"Ocular Therapeutix Reports First Quarter 2022 Financial Results and Business Update","dt":"04:01PM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-reports-first-quarter-200100519.html"},{"t":"Ocular Therapeutix to Report First Quarter 2022 Financial Results","dt":"Apr-26-22 08:00AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-report-first-quarter-120000459.html"},{"t":"AffaMed Therapeutics Announces New Drug Approval for DEXTENZA in Macau for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery","dt":"Apr-12-22 10:46PM","a":"PR Newswire","u":"https:\/\/finance.yahoo.com\/news\/affamed-therapeutics-announces-drug-approval-024600378.html"},{"t":"Ocular Therapeutix (OCUL) Reports Q4 Loss, Lags Revenue Estimates","dt":"Feb-28-22 05:35PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-ocul-reports-q4-223510243.html"},{"t":"Ocular Therapeutix To Report Fourth Quarter and Year-End 2021 Financial Results","dt":"Feb-22-22 08:00AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-report-fourth-quarter-130000236.html"},{"t":"Hikari Power Ltd Buys Alphabet Inc, Vanguard Health Care ETF, Bristol-Myers Squibb Co, Sells ...","dt":"Jan-12-22 09:38AM","a":"GuruFocus.com","u":"https:\/\/finance.yahoo.com\/news\/hikari-power-ltd-buys-alphabet-143805601.html"},{"t":"Ocular Therapeutix Announces Topline Results for Phase 2 Clinical Trial of OTX-DED for the Short-Term Treatment of Dry Eye Disease","dt":"Dec-06-21 07:00AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-announces-topline-results-120000842.html"},{"t":"Ocular Therapeutix Stock Gains As Court Invalidates Drug Delivery Patent From Mati","dt":"Nov-09-21 01:17PM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-stock-gains-court-181755620.html"},{"t":"Ocular Therapeutix Reports Third Quarter 2021 Financial Results and Business Update","dt":"04:01PM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-reports-third-quarter-210100168.html"},{"t":"Ocular Therapeutix to Present Data at the American Academy of Optometry Annual Meeting 2021","dt":"Nov-01-21 08:00AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-present-data-american-120000910.html"},{"t":"Ocular Therapeutix to Present Data at the American Academy of Ophthalmology (AAO) 2021 Virtual Annual Meeting","dt":"08:00AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-present-data-american-120000482.html"},{"t":"Mid-Afternoon Market Update: Nasdaq Down 70 Points; Ocular Therapeutix Shares Drop","dt":"Oct-22-21 03:30PM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/mid-afternoon-market-nasdaq-down-193019198.html"},{"t":"Ocular Therapeutix Stock Slumps; Dry-Eye Drug Misses Trial Endpoint","dt":"09:31AM","a":"TheStreet.com","u":"https:\/\/www.thestreet.com\/investing\/ocular-therapeutix-shares-slump-dry-eye-drug-misses-endpoint?puc=yahoo&cm_ven=YAHOO"},{"t":"2 Small-Cap Stocks With Substantial Upside; Raymond James Says Buy","dt":"Oct-17-21 08:35PM","a":"TipRanks","u":"https:\/\/finance.yahoo.com\/news\/2-small-cap-stocks-substantial-003559841.html"},{"t":"Ocular Therapeutix Announces Appointment of Karen-Leigh Edwards as Senior Vice President of Technical Operations","dt":"Sep-28-21 08:00AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/ocular-therapeutix-announces-appointment-karen-120000286.html"}]}